Article · 21 Jul 2026
ArticlePublished 7 Mar 2024
Radiation Pneumonitis After Sequential Radiation and Trastuzumab-Deruxtecan: A Case Report and Literature Review
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Trastuzumab Deruxtecan (T-DXd) and lung radiotherapy have each been independently associated with pneumonitis. We present a case of a patient with metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer who developed pneumonitis following sequential palliative lung radiotherapy and T-DXd. T-DXd was discontinued, and symptoms resolved after corticosteroids. The literature review identified T-DXd-induced pneumonitis rates of 11.4% across all tumor types and 10.8% in seven breast cancer studies, higher than other anti-HER2 therapies. Additional studies should be done to characterize the risk of combining radiotherapy with T- DXd.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Oncology & Cancer Case Reports.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOncology & Cancer Case Reports
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ravneet K. Dhanoa”
- BylineArticles whose byline prints “Robert W. Gao”
- BylineArticles whose byline prints “Kaitlin W. Qualls”
- BylineArticles whose byline prints “Elsa A. Sutton”
- BylineArticles whose byline prints “Kathryn J. Ruddy”
- BylineArticles whose byline prints “Dean A. Shumway”
- BylineArticles whose byline prints “Robert W. Mutter”